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ABSTRACT
Endocytic trafficking is an essential process in eukaryotic cells, specifically for the
transport of nutrients, membrane components, and receptors. Cargo destined for
endocytic traffic is internalized at the cell surface via clathrin-dependent and clathrinindependent pathways, and brought to the early or sorting endosomes. From there,
cargo is further trafficked to lysosomes for degradation, trafficked to other compartments
in the cell, or recycled back to the cell surface (either directly or via the endocytic
recycling compartment).
Mammalian C-terminal Eps15 homology domain-containing proteins, or EHD
proteins (EHD1 to 4), are a family of highly conserved ATPases that function as key
regulators of specific steps of the endocytic recycling process in metazoans. Research
has shown that EHD proteins can oligomerize and bind to negatively charged
membranes, which stimulates nucleotide hydrolysis. This is thought to assist in the
process of membrane tubulation or the budding of vesicles, which is important in the
movement of cellular components. Additionally, EHD proteins contain EH domains,
which are known to bind to asparagine-proline-phenylalanine (NPF) motif-containing
peptides, suggesting hundreds of potential interacting partners, albeit only a handful are
thus far experimentally validated.
Recent findings have implicated EHD proteins in endothelial cells. Endothelial
cells (ECs) form a barrier between blood and tissues, and play an essential role in many
vital physiological functions including delivery of nutrients, angiogenesis, and innate and
adaptive immune responses. Despite sharing a common purpose, ECs are structurally
and functionally heterogeneous. Immunofluorescence staining of sections from multiple
wild type mouse organs was carried out and the results support a conclusion of
differential expression of EHD proteins within different endothelial beds. In vitro analysis
of multiple cultured endothelial cell lines showed that differential EHD protein expression
is lost as all four EHD proteins were expressed. Finally, siRNA-mediated knockdown of
individual EHD proteins was found to affect tubulation of endothelial cells grown in
reconstituted basement (Matrigel). These findings support a role for EHD proteins in
endothelial cell biology.
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CHAPTER 1: INTRODUCTION
A. Endocytic Trafficking: An Overview
Endocytic

trafficking

requires

a

system

of

membranous

compartments

responsible for the sorting of internalized cargo and delivering it to various intracellular
destinations. These trafficking routes are complex and provide multiple functions,
contributing to important cellular process such as receptor signaling, migration, polarity,
junction formation, and membrane repair (Grant & Donaldson 2009). In the most general
sense, traffic involves endocytosis of materials at the cell surface where they are
delivered to the early endosome (EE) for sorting. From there, these materials can move
onto the late endosome/lysosomal pathway for degradation, recycle back to the cell
surface, or be brought into the trans-Golgi network (TGN) (Grant & Donaldson 2009)
(Figure 1). Transcytosis is an offshoot of membrane traffic, utilizing the endosomal
system to move cargo across a polarized cell to the opposite membrane, and will be
addressed in a later section.
Regulating specific steps of endocytic traffic are the small GTP-binding Rab
proteins (Smith et al. 1991). These proteins cycle between an active GTP-bound state
(on) and inactive GDP-bound state (off). Conversion to the ‘on’ state with the assistance
of guanine nucleotide exchange factors (GEFS) allows Rabs to bind and activate
downstream effectors, resulting in traffic events such as vesicle formation, movement,
and fusion with membranes. GTPase-activating proteins (GAPs) promote GTP
hydrolysis, returning them to an off state (Smith et al. 1991). Different Rabs localize to
distinct compartments and regulate specific molecular events, contributing to the high
fidelity of membrane trafficking (Watson & Pessin 2006; Grant & Donaldson 2009). Rabs
that are commonly associated with specific compartments and steps of trafficking will be
mentioned below.
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Slow Recycling

Fast
Recycling

Figure 1: Model for endocytic recycling. Endocytic recycling involves the uptake of cargo
via clathrin-dependent or independent methods of endocytosis followed by sorting in the early,
or sorting, endosome. Cargo is ultimately either recycled back to the cell surface via fast and
slow recycling mechanisms or is degraded in the lysosome. Additionally, cargo may be
trafficked to and from the trans-Golgi network via retrograde transport.
Adapted from Hsu, V. W. et al. Getting active: protein sorting in endocytic recycling. Nature
Reviews Molecular Cell Biology, 3(5) 2012.
Reprinted by permission from Macmillan Publishers Ltd: [NATURE REVIEWS MOLECULAR
BIOLOGY] V. W. Hsu, Ming Bai, Jian Li, copyright (2012)

Cellular cargo is first internalized via endocytosis. Endocytic events can be
subdivided into clathrin-dependent (CDE) and clathrin-independent endocytosis (CIE)
(Conner & Schmid 2003; Doherty & McMahon 2009). CDE, the best-studied pathway,
begins with the adapter protein AP-2 recognizing and binding the intracellular domain of
a protein, bridging the cargo to the scaffold protein clathrin. A clathrin-coated pit is
formed, and the GTPase dynamin regulates the fission of the budding vesicle from the
plasma membrane (Hinshaw 2000; Maxfield & McGraw 2004). Once the vesicle has
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entered the cell, the clathrin coat and adaptor proteins are removed and recycled
(Maxfield & McGraw 2004). Receptor-mediated endocytosis commonly utilizes this
route, and transferrin receptor (TfR) and low density lipoprotein (LDLR) are well-known
cargoes of CDE (Grant & Donaldson 2009).
Many cell surface proteins lack the intracellular domain required for CDE, and,
therefore, can be internalized via one of several clathrin-independent pathways. CIE
pathways can be categorized based on their dependence on dynamin (Mayor & Pagano
2007). Caveolae-mediated endocytosis is dynamin dependent and well characterized.
Caveolae are invaginations that are characterized by their flask-shaped invaginations
and the presence of caveolin (Parton 2003), and that are enriched with sphingolipids and
cholesterol (Aboulaich et al. 2004; Lemaître et al. 2005; Sprenger et al. 2004). Caveolae
carry a variety of cargos including receptors, lipids, and pathogens (Mayor & Pagano
2007). Another dynamin-dependent CIE pathway involves RhoA-mediated internalization
via detergent-resistant membranes (Mayor & Pagano 2007; Lamaze et al. 2001). One
form of dynamin-independent CIE requires the GTPase ARF6. This pathway has been
identified as the internalization route for MHC class I molecule, β1-integrin, and Ecadherin (Radhakrishna & Donaldson 1997; Walseng et al. 2008; Brown et al. 2001;
Powelka et al. 2004). Finally, specialized forms of CIE involve actin-driven events and
include phagocytosis and macro-pinocytosis (Sigismund et al. 2012). This thesis does
not provide a comprehensive list of all endocytosis pathways that have been identified,
and it is important to point out that these pathways are complex and there is evidence of
crosstalk between them.
Once internalized, most endocytosed material is delivered to the early endosome
(EE) via intermediate vesicles or tubules and then sorted (Mayor & Pagano 2007). EEs
are tubular-vesicular compartments located near the periphery of the cell. Rab5, EEA1,
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and PI3K serve as markers for EEs and are important in their function (Grant &
Donaldson 2009). From the EE, endocytic cargo can travel back to the cell surface,
continue on to the endocytic recycling compartment (ERC), or remain in the EE as it
matures and moves towards degradation in the lysosomes. Cargo that recycles to the
plasma membrane leaves the EE rapidly in vesicles that pinch off from tubules (Grant &
Donaldson 2009), a process regulated by Rab4. EEs are slightly acidic, promoting the
dissociation of ligands from receptors. The EE then moves along microtubules further
into the cell, acquiring hydrolases that drop the pH further as part of the maturation
process to late endosome (LE). Cargo is then delivered to the lysosomes for
degradation. Proteins fated for the lysosome are modified by the addition of ubiquitin to
their lysine residues, serving as a ‘termination signal’ (Maxfield & McGraw 2004).
Cargo that isn’t rapidly recycled or degraded moves onto the ERC via extension
of tubules from the EE that lose Rab5 and acquire Rab11 (Grant & Donaldson 2009).
The ERC is usually located at microtubule-organizing centers and consist of long-lived
organelles. While there are several fates for cargo within the ERC, most of the cargo
recycles to the cell surface via the slow recycling pathway. Movement between the ERC
and trans-Golgi network can occur as well (Maxfield & McGraw 2004). Interestingly, in
some instances receptors can be trafficked from the ERC to specialized compartments,
such as the case with GLUT4. GLUT4 is stored in insulin-regulated compartments
(IRCs) and upon stimulation with insulin GLUT4 is recycled to the plasma membrane
from this compartment. This process is dynamic, and GLUT4 is equally present in the
ERC (Zeigerer et al. 2002; Lampson et al. 2001; Maxfield & McGraw 2004).
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B. EHD Proteins: Regulators of Endocytic Traffic
One subset of proteins involved in endocytic trafficking events is characterized by
multiple Eps15 homology (EH) domains, which were first identified as three repeated
copies at the N-terminus of epidermal growth factor receptor tyrosine kinase substrate
Eps15 (Fazioli et al. 1993; Wong et al. 1994). Since then, many EH domain-containing
proteins have been implicated in early endocytic events (Confalonieri & Di Fiore 2002;
Santolini et al. 1999). The EH domain is comprised of approximately 100 highly
conserved amino acids (Fazioli et al. 1993; Wong et al. 1994). Structurally, the EH
domain forms a fold containing two EF-hands, or helix-loop-helix motifs, connected by a
short antiparallel β-sheet. These EF-hands are also capable of binding calcium (de Beer
et al. 1998; Confalonieri & Di Fiore 2002). One of the functions of the EH domain is to
recognize asparagine-proline-guanine (NPF) motifs (Santolini et al. 1999; Polo et al.
2003; Salcini et al. 1997). This interaction occurs within a hydrophobic pocket found on
the surface of the EH domain, facilitating a close proximity between a highly conserved
tryptophan and the asparagine of the NPF motif (de Beer et al. 1998; de Beer et al.
2000; Rumpf et al. 2008).
A subfamily of the EH-domain containing proteins, the C-terminal Esp15
homology domain-containing proteins (EHD1-4), is unique in that these proteins contain
a single C-terminal EH domain. EHD proteins are conserved amongst different species.
Some, such as C. elegans and D. melanogaster have a single ortholog of human EHD1
(Rme-1 and Past1 respectively) (Grant et al. 2001; Olswang-Kutz et al. 2009). Initial
studies in C. elegans found that mutations in RME-1 led to defects in endocytic
trafficking (Grant et al. 2001). Additionally, EHDs have been linked to Rab proteins, their
effectors, and recycling of receptors, supporting their importance in endocytic trafficking
events (discussed below).
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The EHD proteins are encoded by four different genes that are located on
separate chromosomes (Pohl et al. 2000). Despite this, EHD proteins are highly
conserved, sharing an overall amino acid sequence identity of 71-86% (Pohl et al. 2000).
They are approximately 60 kDa in mass and are characterized as having three major
functional domains (Figure 2). The C-terminal EH domain facilitates protein-protein
interactions. The N-terminal G-domain, or P-loop, is a nucleotide-binding site that
preferentially hydrolyzes ATP, instead of GTP, which is preferentially used by GTPases
such as Rabs and dynamin. Finally, the central helical (or coiled-coiled domain)
mediates homo- and hetero-oligomerization. It has been proposed that EHD proteins
function in membrane fission through dimerization and lipid binding, powered by the
hydrolysis of ATP (Daumke et al. 2007). Previous studies have suggested roles for EHD
proteins in membrane bending, tubulation, and vesiculation (Pant et al. 2009; Daumke et
al. 2007; Jakobsson et al. 2011; Cai et al. 2012). A very recent study has provided a
clearer image of their functions, suggesting that EHD1 and 4 are vesiculators and EHD3
is a tubulating protein (Cai et al. 2013).

Figure 2: EHD protein architecture. EHD proteins have 3 characteristic domains. EHD
proteins differ from other EH domain-containing proteins in that they contain a single EH
domain at the C-terminus. The EH domain recognizes and binds other proteins that contain
NPF motifs. The N-terminus contains an ATP-binding G-domain, or P-loop that binds
nucleotides. Finally, there are two helical domains that are important for oligomerization.
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EHD1 is the most extensively studied of the EHD proteins, most likely because of
its sequence homology to orthologs found in other species. A prominent function for
EHD1 is the regulation of receptor recycling from the endocytic recycling compartment to
the plasma membrane, including receptors that have been internalized via both CIE and
CDE. Receptors endocytosed via CDE associated with EHD1 include Transferrin
receptor (TfR) (Mintz et al. 1999; Lin et al. 2001), GLUT4 glucose transporter (which can
also internalize via CIE) (Guilherme, Soriano, Furcinitti, et al. 2004), and AMPA receptor
(Park et al. 2004; Carroll et al. 2001). Receptors endocytosed via CIE include MHC class
I and II molecules (Caplan et al. 2002; Walseng et al. 2008), β-1 integrin (Jović et al.
2007), and cystic fibrosis transmembrane conductance regulator (CFTR) (Picciano et al.
2003; Holleran et al. 2013). In respect to GLUT4 recycling, EHD1 interacts with EHBP1,
which is required for mobilization of GLUT4 upon stimulation with insulin in adipocytes
(Guilherme, Soriano, Furcinitti, et al. 2004). Additionally, EHD1 associates with other
proteins important in the recycling step of endocytic trafficking including Rabenosyn-5
(an effector of Rab4/Rab5) (Naslavsky et al. 2004), and Syndapin I and II (Xu et al.;
Braun et al. 2005).
In addition to trafficking receptors from the ERC to the plasma membrane, there
is evidence that EHD1 is involved in transport from the EE to the ERC. This is supported
by EHD1/3’s interaction with Rab11-FIP2 (Naslavsky 2005). EHD1 is also associated
with Rab35, which forms a complex with MICAL-L1 and other proteins to promote EE to
ERC transport (Kobayashi & Fukuda 2013). EHD1 has been implicated in endocytic
events, including the internalization of low-density lipoprotein (LDL) receptor (Naslavsky
et al. 2007), L1/neuron-glia cell adhesion molecule (NgCAM) along with EHD4 (Yap et
al. 2010), and IGF1R (Rotem-Yehudar et al. 2001). Finally, EHD1 is involved with
retrograde transport in association with the retromer complex (Gokool et al. 2007).
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More recently, research has revealed novel roles for EHD1 in cell biology. Along
with MICAL-L1, EHD1 is involved in microtubule alignment during mitosis, assisting in
chromosome alignment and cytokinesis (Reinecke et al. 2015). Additionally, along with
EHD3, EHD1 localizes to the ciliary pocket and is indispensable for early assembly
events of cilia (Lu et al. 2015).
In

vivo

studies

utilizing

Ehd1-knockout

mice

revealed

defects

in

spermatogenesis, muscle fibers, and ocular development. Ehd1-null mice are born at
sub-Mendelian ratios and are smaller at birth. Additionally, males are infertile and testes
are smaller. This is due to a disruption in the spermatogenic cycle that results in the
absence of mature spermatozoa (Rainey et al. 2010a). Ehd1 deletion also leads to
smaller muscle fibers, most likely as a result of reduced myoblast fusion (Posey et al.
2014). Finally, the most recent study done in Ehd1-knockout mice shows that
approximately 50% are born with some form of ocular deformity including small/absent
lenses and cataracts. Defects in epithelial proliferation and survival and loss of cellular
junction expression contributed to this phenotype (Arya et al. 2015).
EHD2 is the first and only EHD protein to have its complete structure solved
(Daumke et al. 2007). EHD2 has been implicated in the regulation of few receptors, but it
has obvious importance in endocytic trafficking. EHD2 binds EHBP1 and regulates the
internalization of transferrin receptor and GLUT4, both internalized via clathrin-mediated
endocytosis (Guilherme, Soriano, Bose, et al. 2004). On the other hand, EHD has been
implicated in the recycling of transferrin receptor from the ERC as well (George et al.
2007). EHD2 has also been linked to clathrin-independent endocytosis, specifically
caveolae mediated. EHD2 forms oligomers that localize to caveolae at the plasma
membrane in an ATP dependent process (Stoeber et al. 2012). Additionally, EHD2 has
been found to complex with pacsin2, a caveolaer protein (Hansen et al. 2011; Ludwig et
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al. 2013). Along with EHD1, EHD2 also interacts with Fer1L5 as well as another ferlin
family protein, myoferlin, and depletion of EHD2 reduces myoblast fusion (Posey et al.
2011; Doherty et al. 2008). Laser-induced injury of muscle fibers causes an
accumulation of fluorescently labeled EHD2 to the injury site in a dome shape where a
third ferlin family member, dysferlin, localizes (Marg et al. 2012). This suggests a novel
role for EHD proteins in plasma membrane repair. Finally, in a function unrelated to
cellular traffic, EHD2 was recently found to shuttle to the nucleus where it can repress
transcription of cyclin-dependent kinase inhibitor 1 (CDKN1A) (Pekar et al. 2012).
EHD3 is most similar in sequence to, and directly binds to, EHD1 (Galperin et al.
2002). EHD3 functions differently, though, in that it is primarily involved in early recycling
events, specifically, EE to ERC transport (Galperin et al. 2002; George et al. 2007).
EHD3 has also been associated with early endosome to Golgi retrograde transport
(Naslavsky et al. 2009). More recently, EHD3 was found to play in a role in the rapid
recycling of the Avβ3-integrin from the early endosome to plasma membrane, playing an
important role in cell survival and adhesion (Waxmonsky & Conner 2013). Like EHD2,
EHD3 undergoes post-translational modification via SUMOylation. In the case with
EHD3, SUMOylation at Lysine residues 315 and 511 are involved in the tubulation of the
endocytic recycling compartment and necessary are for the successful recycling of
transferrin receptor to the cell surface (Cabasso et al. 2015). The most extensive studies
involving EHD3 have been in the mouse heart. EHD3 was found to interact with AnkyrinB, regulating the sodium/calcium exchanger (NCX1) in cardiomyocytes (Gudmundsson
et al. 2010). In multiple mammalian heart failure models, EHD3 along with NCX1 was
upregulated, suggesting EHD3 is an important component to cardiac remodeling post
injury (Gudmundsson et al. 2012). Later the same group implicated EHD3 in the
trafficking of L-type calcium channel type 1.2 (Cav1.2) in myocytes and voltage gated T-
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type calcium channels 3.1 and 3.2 (Cav3.1/Cav3.2) in atrial myocytes (Curran et al.
2014; Curran et al. 2015).
EHD4, which is also called pincher, has primarily been identified in transport from
the early endosome to the endocytic recycling compartment or the lysosomal pathway
(George et al. 2007; Sharma et al. 2008). It was first found to interact with collagen type
VI as an extracellular protein (Kuo 2001). In vivo, male Ehd4 knockout mice display fifty
percent smaller testis size and are sub-fertile, suggesting a role for EHD4 in germ cell
development.

While knockout mice show no evidence of hearing disability, EHD4

interacts with and regulates cadherin 23, a protein important for delivering mechanical
signals in the inner ear (Sengupta et al. 2009).
EHD4 expression is prominent in the brain, and in neuronal cells EHD4 is
involved in the trafficking in several receptors. Despite this, there are no neurological
phenotypes reported in Ehd4-knockout mice to date. EHD4 is linked to pinocytic
endocytosis of the nerve growth factor receptors TrkA and TrkB, promoting their
signaling (Shao et al. 2002; Valdez et al. 2005; Philippidou et al. 2011). Nogo-A is a
protein responsible for axonal growth inhibition, and its internalization is also regulated
by EHD4 (Joset et al. 2010). EHD4 oligomerizes with EHD1, and together they regulate
the internalization of the Ln/NgCAM in neurons as well. In Drosophila, NUMB is
neurological protein important in cell fate and it interacts with EHD4.
One final note about EHD proteins is their ability to compensate for one another.
All 4 mammalian EHD proteins are capable of rescuing the function of Rme-1 when
defective in C. elegans (George et al. 2007). As discussed above, though, it is apparent
that each EHD protein has a distinct function. Additionally, single deletion of an Ehd
gene in mice has resulted in increased expression of other EHD proteins. For example,
EHD1 is upregulated in the ear and testes when Ehd4 is deleted (Sengupta et al. 2009;
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George et al. 2010). Also, EHD4 is upregulated in glomerular endothelial cells in the
kidney of Ehd3-null mice (discussed below) (George et al. 2011).
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C. Localization of EHD Proteins in Endothelial Beds
Only a handful of journal articles address EHD protein expression within
endothelial beds. Transcriptome analysis show enrichment of ehd1 expression in
endothelial cells from whole organs, most significantly in the lung, from Tie2GFP mice
(Daneman et al. 2010). Tie2GFP mice have endothelial cell-specific expression of GFP.
When isolated and co-cultured with glial cells to recreate the blood-brain barrier
environment, bovine brain capillary endothelial cells increase expression of Ehd1 mRNA
and protein compared to cells that have not been co-cultured (Deracinois et al. 2012).
Through immunofluorescent staining of mouse tissue sections, EHD2 has been found to
localize within vasculature of skeletal muscle and interlobular arteries of kidneys (Mate
et al. 2012; George et al. 2011). Immunofluorescent staining of liver sections from rats
showed that EHD3 co-localizes with the scavenger receptor Stabilin-1 in sinusoids
(Géraud et al. 2010). A study involving hepatocellular carcinoma in a rat tumor model
found that EHD3 was heavily down regulated in tumor endothelial cells. Further analysis
using IHC found that EHD3 was expressed in sinusoidal endothelial cells of the normal
liver tissue and expression was lost in the endothelium of adjacent tumor endothelium
(Jia et al. 2010). EHD3 has also been found in glomerular endothelia of the mouse
kidney via microarray data, northern blot, western blot, and immunofluorescent staining
analysis (Patrakka et al. 2007; Brunskill & Potter 2010; George et al. 2011). Just from
these few articles, it’s apparent that EHDs are expressed in the endothelium and
perhaps are expressed differentially in different endothelial bed types. Additionally,
changes seen in the vasculature during cancer development may affect EHD protein
expression as well.
Previous studies show when a single EHD protein gene is deleted, there are
compensatory changes in other EHD protein’s expression (Rainey et al. 2010b; George
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et al. 2010; Sengupta et al. 2009). In Ehd3 knockout mice, EHD4 is up regulated in
glomerular endothelial cells. Concurrent deletion of Ehd3 and Ehd4 led to an increase in
EHD2 in the glomerular and peritubular capillary endothelium (George et al. 2011).
Interestingly, removing the compensation of EHD4 in the double knockout mice also
caused thrombotic microangiopathy (TMA), a pathology of the endothelia commonly
seen in conditions such as pre-eclampsia and malignant hypertension (Stillman &
Karumanchi 2007). Additionally, this phenotype is also seen in mice when podocyteexpressed VEGF-A is knocked down in mice (Eremina et al. 2008; Eremina et al. 2003).
Subsequently, Ehd3-/-; Ehd4-/- glomeruli show a more dispersed distribution of VEGFR2
(George et al. 2011). This is the first evidence that EHD proteins may be playing a role in
the trafficking of a receptor (VEGFR2) in endothelial cells.
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D. Vascular Endothelial Cells and Their Heterogeneity
In 1628 William Harvey first described a closed circulatory system that consisted
of arteries and veins while predicting the existence of capillary beds (Aird 2007a). The
purpose of this closed circulatory, or cardiovascular, system is to deliver nutrients and
oxygen to the tissues of the body. This is accomplished when blood is pumped away
from the heart through the arteries, carrying oxygen and nutrients and delivering them to
tissues and cells via the capillary network. This same network also picks up carbon
dioxide and waste, and the blood makes its way back towards the heart through the
veins. Both arteries and veins are made up of three layers: tunica intima (endothelial
cells), tunica media (smooth muscle and connective tissue), and tunica adventitia
(connective tissue). Capillaries differ from arteries and veins in that they consist of just a
layer of endothelium and sometimes connective tissue. Comparing arteries to veins,
arteries have a thick tunica media and pulsate while veins have thin walls and valves
(Aird 2007b).
Wilhelm His was the first to define the term endothelium in 1865 (Aird 2007a).
Endothelial cells (ECs) make up the inner lining of both blood vessels and lymphatics,
covering an approximate area of 1 to 7 m2 and accounting for 60 trillion cells found in the
body (Augustin et al. 1994). ECs are the gatekeepers of the cardiovascular system,
playing a part in many vital physiological functions including delivery of nutrients,
angiogenesis, and innate and adaptive immune responses. The endothelium is
implicated in most, if not all, human diseases and provides immense therapeutic
potential.
The heterogeneous nature of ECs first became obvious when studies using
electron microscopy (EM) in the 60s led to the discovery that there were many types and
that they differed in structure (Florey 1966). While ECs share the same general purpose
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of maintaining a barrier between blood and tissue, their phenotypes vary based on
factors such as their location, endothelial bed type, structure, and function.
ECs vary structurally based on their location. Their thickness can range from less
than 0.1 µm in the smallest capillary ECs to 1 µm in the aorta. Blood flow and shear
stress dictate the shape of ECs. In general ECs from arteries are long and narrow
(spindle shaped), ECs from veins are more short and broad (rectangular), and capillary
ECs are irregularly shaped (Aird 2007a). Interestingly, while most ECs are flat, high
endothelial (post-capillary) venules are plump and cuboidal. This is most likely to
accommodate leukocyte migration (Girard & Springer 1995). Intercellular junctions are
formed between all endothelial cells and include tight and adherens junctions (Dejana
2004; Bazzoni & Dejana 2004). Endothelial cells found in large arteries contain many
tight junctions due to the high exposure to shear stress. Capillaries vary in number of
tight junctions, with the least amount found in the post-capillary venules, again, due to
their function in leukocyte migration. The blood brain barrier, on the other hand, has a
high number of tight junctions in order to protect neural tissues (Aird 2007a).
Endothelial

beds

can

be

categorized

into

three

subsets:

continuous

nonfenestrated, continuous fenestrated, and discontinuous/sinusoidal. Continuous
nonfenestrated endothelia have an uninterrupted basement membrane, and their ECs
are tightly connected. These endothelial beds are found in all arteries and veins in
addition to some capillary beds. Continuous fenestrated endothelia also have a
continuous basement membrane, but cells are interrupted with transcellular pores, or
fenestrae, that are approximately 70 nm in diameter. In most cases, they contain a thin
diaphragm, contributing to permeability. Fenestrated endothelia function as filters and
are found in capillary beds of the kidney (glomerulus and some renal tubules), intestinal
mucosa, and endocrine glands. Fenestrated endothelia can be found in other vessels
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during development, but are lost over time (Yoshida et al. 1988; Stewart & Hayakawa
1994). Discontinuous endothelial beds are characterized by their poorly formed
basement membrane in addition to the presence of large fenestrae (100-200 nm in
diameter) and large gaps. These endothelia are most commonly associated with the
sinusoids of the liver (Aird 2007a). Figure 3 provides a summary of the characteristics of
ECs and the endothelial beds they make up in different blood vessel types.

Figure 3: Endothelial cells of arteries, veins, and capillaries. Endothelial cells vary
depending on the blood vessels they line. Structurally they vary between artery, vein, and
capillary bed. Arteries and veins are composed of continuous endothelial cells. Capillaries can
further be broken down into continuous, fenestrated, and discontinuous and are found in
different tissues and organs.
From: Aird, W.C., 2007b. Phenotypic heterogeneity of the endothelium: II. Representative
vascular beds. Circulation research, 100(2), pp.174–90.
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Both the structure of endothelial cells and the organization of endothelial beds
are dynamic and can be altered. Experiments have shown that reorienting ECs will
cause them to realign with the direction of blood flow (Flaherty et al. 1972). Both
fenestrated and sinusoidal endothelia formation and maintenance are dependent on
VEGF signaling. Loss of VEGF can result in the loss of fenestrated endothelia (Maynard
et al. 2003; Eremina et al. 2008; Carpenter et al. 2005). Stimulation of VEGF, on the
other hand, can result in induction of fenestrae in continuous endothelium (Roberts &
Palade 1995). Disease can also result in disruption of endothelial beds. For example,
liver disease can result in loss of sinusoids and gain of continuous endothelium
(Bhunchet & Fujieda 1993).
Endothelia also display functional heterogeneity based on blood vessel type and
location. One function of the endothelium is to be permeable. Capillaries are basally
permeable in that there is continuous movement of material between the blood and
tissues. Post-capillary venules, in contrast, become permeable when induced by an
agonist – usually as an inflammatory response. Additionally, the post-capillary venule is
also the site of leukocyte transmigration, which is facilitated by adhesion molecules such
as P- and E-selectins. Another function of endothelium is to maintain homeostasis,
including maintenance of the blood by expressing coagulants and anticoagulants, all of
which are expressed differentially in different blood vessels. In addition to these
functions, different endothelial beds have specialized functions. Examples include
filtration in glomerular endothelial cells of the kidney and sinusoids of the liver. The
sinusoids in the liver are also responsible for scavenging and immune tolerance. Finally,
endothelial cells are generally considered quiescent. Endothelium in reproductive organs
in females, though, undergoes high levels of proliferation and angiogenesis (Aird 2007a).
Table 1 summarizes the different levels of heterogeneity seen in endothelial cells.
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Table 1: Endothelial cell heterogeneity. Endothelial cells vary by structure, expression
patterns, and function. These traits are greatly affected by their location, such as blood vessel
or organ (Aird 2003).

In general, due to their heterogeneity, identifying ECs is a difficult task. For
example, ultrastructural features such as caveolae and Weibel-Palade bodies can be
used to identify most endothelia types through microscopy, but caveolae are commonly
found in many other cell types and not all ECs have Weibel-Palade bodies (Weibel &
Palade 1964). Additionally, gene expression in ECs is differential throughout the entire
vasculature, making it hard to identify true markers of endothelial cells (Aird 2003). Table
2 lists common markers used for endothelial cells. Other markers have been used for
specialized vasculature as well, including Glut-1 for blood brain barrier endothelium and
GlyCAM-1 for high endothelial venules (Garlanda & Dejana 1997). It is important to point
out that in addition to uneven expression of these markers, some of these molecules are
also expressed in non-endothelial cell types. Currently, the most commonly used
markers to encompass most endothelial cells are platelet/endothelial cell adhesion
molecule (PECAM)-1 (or CD31) and vascular endothelial (VE)-cadherin (Aird 2007a;
Garlanda & Dejana 1997).
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Table 2: Endothelial specific markers. The above table lists known markers for endothelial
cells in both humans and mice. Asterisks note markers for microvascular endothelial cells.
These proteins/markers can identify other cell types as well (Garlanda & Dejana 1997). Table
adapted from Garlanda & Dejana 2007.
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E. Endocytic Trafficking in Endothelial Cells
Just like any other cell, endothelial cells are capable of trafficking cellular cargo.
In addition to conventional endocytic trafficking (as described above), ECs also carry out
transcytosis to deliver materials to underlying tissues. While transcytosis is seen in other
polarized cell types, it was first identified within capillaries in the 1950s (Tuma &
Hubbard 2003). Transcellular transport involves the movement of materials from one
side to the other through the cell as opposed to between adjacent cells, which is seen in
paracellular transport. Only continuous and fenestrated endothelium participate in
transcytosis and capillaries are most actively utilizing transcytosis (Simionescu 1983;
Simionescu & Simionescu 1991). Movement of cargo can occur in both directions (blood
to tissue and vice versa) and by both bulk- and receptor-mediated mechanisms (Tuma &
Hubbard 2003).
While ECs contain the machinery of endocytic recycling, it is less abundant and
more localized at the perinuclear region of the cell. Unlike other cell types, CIE is not the
prevalent route for internalization seen in ECs. The population of coated pits in ECs
tends to be significantly lower than that of non-coated vesicles. TfR and LDLR are
traditionally internalized via CIE, and this holds true in ECs (Muro et al. 2004).
Additionally, recycling of the inducible adhesion molecules E- and P-selectin is regulated
by clathrin-mediated uptake (von Asmuth et al. 1992; Straley & Green 2000) . Most
notably, ECs of the liver sinusoids rely heavily on CIE for the internalization of IgG
immune complexes by Fe receptors (Kosugi et al. 1992).
Caveolae-dependent endocytosis is more prominent in ECs and is also utilized
as the entry point for transcytosis (Muro et al. 2004). In addition to contributing to
internalization, caveolae contain the components required for vesicle formation, fission,
docking, and fusion, allowing for involvement in other physiological functions (Schnitzer
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et al. 1995). Indeed, caveolae have now been implicated in many EC functions such as
permeability, mechanotransduction, and redox signaling (Sowa 2012). Another area in
which caveolae have been implicated is during angiogenesis. Caveolae merge and form
large structures during angiogenesis; overexpression of caveolin-1 enhanced caveolae
formation, leading to increased tubule formation in ECs (Esser et al. 1998; Liu et al.
2002). Additionally, VEGF receptor (VEGFR2), whose signaling is required for
angiogenesis, localizes to caveolae. Given previous studies associating EHD2 with
caveolae, EHD proteins may play a role in endothelial trafficking and function as well.
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F. Hypothesis
Endothelial cells utilize endocytic trafficking for many cellular processes including
membrane repair, angiogenesis, and receptor trafficking. Previous publications already
show that EHD proteins, which are key regulators in trafficking, are expressed in
endothelial beds of multiple organs. Given the heterogeneous nature of ECs as well as
the distinct roles of different EHD proteins, it is hypothesized that EHD proteins will be
expressed differentially based on endothelial bed type. Based on previous data, we
predict that EHD2 is expressed in continuous nonfenestrated endothelium while EHD3 is
expressed in continuous fenestrated and sinusoidal capillary beds. EHD1 may be
expressed in endothelial beds where tight junctions are more prevalent, such as arteries.
Additionally, we predict that EHD proteins will be also expressed in endothelial cell lines,
and that knockdown of EHD proteins in vitro will disrupt expression of various endothelial
receptors and affect tubulation.
To test these hypotheses and to begin to understand the role of EHD proteins in
endothelial cell biology, the following will be accomplished:
1. Determine EHD expression throughout different endothelial beds of wild type
mouse organs via immunofluorescent staining analysis.
2. Determine EHD expression in endothelial cell lines via western blot analysis
and examine whether expression varies between different cell lines.
3. Assess the effects of siRNA-mediated knockdown of EHD1 and EHD2 in vitro
on VEGFA-stimulated tubulation of endothelial cells in growth factor-reduced
Matrigel.
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CHAPTER 2: METHODS AND METHODS
A. Tissue Staining
The following organs were harvested from perfused wild type (C57Bl6) mice:
kidney, heart, lungs, liver, and pancreas. Organs were formalin fixed overnight,
embedded in paraffin, and sectioned (5 µm) for immunofluorescent staining. Sections
were deparaffinized in xylene and rehydrated in graded ethanols followed by a PBS
wash. Slides were then boiled in a citrate-based antigen unmasking solution (Vector
Laboratories) in a large flask in the microwave followed by three washes in water and
one wash in PBS. Sections were blocked in PBS/5% fetal bovine serum (FBS) for 1
hour. Rabbit monoclonal anti-EHD1 primary antibody (Abcam) was commercially
purchased and used at a dilution of 1:500 in PBS/5% FBS. Polyclonal rabbit anti-EHD2
and EHD3 primary antibodies were used at a 1:200 dilution. Fluorescein-labeled tomato
lectin (from L. esculentum) and GSL 1 – isolectin B4 (from G. simplicifolia) were used at
1:250 and 1:50 dilutions, respectively (Vector Labs). Donkey anti-rabbit Alexa Fluor 594
secondary antibody was used at 1:500 dilution (Invitrogen). Slides were mounted in
Vectashield containing DAPI and sealed with clear nail polish. Images were acquired
with EVOS FL Auto microscope (Life Technologies).
B. Cell Culture
Human umbilical vein endothelial cells (HUVECs) were grown in Media 200
supplemented with low serum growth supplement (LSGS) (ThermoFisher Scientific).
EA.Hy926 cells (ATCC) were grown in Dulbecco’s Modified Eagle Medium (DMEM)
containing 10% FBS, 100 units/ml penicillin, and 100 µg/ml streptomycin (Invitrogen).
Human microvascular endothelial cells (HMEC1) were provided by Dr. Rakesh Singh’s
lab (University of Nebraska Medical Center) and were grown in RPMI-1640 Medium
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containing 5% FBS, L-glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin
(Invitrogen). Mouse mammary fat pad microvascular endothelial cells (MFP MVECs)
were also provided by Dr. Rakesh Singh’s lab and maintained in flasks coated with 0.2%
gelatin. MFP MVECs were maintained in DMEM containing 10% FBS, 2 mM GlutaMAX
(Gibco), 1 mM sodium pyruvate (Invitrogen), 0.1 mM non-essential amino acids
(Invitrogen), 1 X MEM vitamins (MediaTech), 100 units/ml penicillin and 100 µg/ml
streptomycin (Invitrogen), 0.25 µg/ml amphotericin B (Fungizone) (ThermoFisher
Scientific), and 40 µg/ml gentamicin (Invitrogen). MFP MVECs were isolated from H2Kb-ts-A58 mice (Immortomice from Charles River Laboratories), and express SV40
antigen at 33˚C and lose SV40 expression at 37˚C. All cell lines were passaged using
trypsin-EDTA solution, except for MFP-MVECs, which required Accutase dissociation
solution (Innovative Cell Technologies). All cells were grown in an atmosphere of 95%
air and 5% CO2.
C. Antibodies and Western Blotting
Cells were lysed in 10% Triton X cell lysis buffer (1 M Tris 7.5, 5 M NaCl, 10%
Triton X-100, 100 mM VO4, 1 M NaF, 50 nM PMSF) overnight at 4˚C. Lysates were
clarified and protein concentration was determined in a 96 well plate using the Bio-Rad
Dc Protein Assay, using bovine serum albumin as a standard. Aliquots containing 40 µg
of protein were prepared in sample buffer and separated using 7.5% SDSpolyacrylamide gel electrophoresis (PAGE), then the proteins were transferred onto
polyvinylidene difluoride (PVDF) membranes. Membranes were immunoblotted with
appropriate primary antibodies followed by 1:20,000 dilutions of horseradish peroxidase
(HRP)-conjugated protein A, Goat anti-Rabbit, or Goat anti-mouse secondary antibodies.
Signals were detected using enhanced chemiluminescent western blotting substrate
(ThermoFisher Scientific) and developed on Blue Ultra Autorad film (ISC Bioexpress).
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Polyclonal rabbit anti-EHD1 (also detects EHD4) and EHD2 were used at 1:2000
dilutions and anti-EHD3 was used at a 1:1000 dilution. Rabbit anti VEGFR2 antibody
was purchased from Cell Signaling and was used at a 1:1000 dilution.
D. Gene Knock-Down by Small Interfering RNA (siRNA)
Small interfering RNA (siRNA) oligonucleotides (synthesized by Dharmacon)
were transfected into EA.Hy926 cells using Lipofectamine 2000 transfection reagent
(ThermoFisher Scientific) following the manufacturer’s instructions. Demonstrable
knockdown of protein expression was seen within 48 hours of transfection as assessed
by western blotting. For EHD2, the ON-TARGET SMART-pool siRNA from Dharmacon
GE was used. For EHD1, the following sequence was designed: 5’-gaa aga gat gcc caa
tgt c (Dharmacon). As an irrelevant siRNA control, Non-targeting siRNA #5 was used
(Dharmacon).
E. Tubulation Assays
EA.Hy926 cells were transfected with siRNAs against EHD 1-4 (along with
control siRNA), and 48 hours after transfection cells were passaged and replated into
T25 flasks so that they were 80-90% confluent the following day. On the second day,
cells were passaged a second time and plated in triplicate in a 96-well plate containing
100% growth factor-reduced Matrigel (BD Biosciences) in the following conditions:
serum-free media, media + 50 ng/ml VEGFA165 (Peprotech), and media + 15 µm
sulforaphane (Sigma). After 6 hours, cells were incubated with 6 µM Calcein AM
(Trevigen) for 15 minutes and imaged using the EVOS FL Auto microscope. Image J
software was used to analyze images, and tubulation was assessed by average branch
point and tubule number.
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CHAPTER 3: RESULTS
A. EHD Proteins are differentially expressed in a variety of endothelial beds from
multiple organs from wild type mice.
EHD proteins have distinct expression patterns in organs and tissues, and
evidence suggests differential expression in endothelial beds. To determine expression
patterns of EHD proteins in endothelium, immunofluorescent staining was performed on
the following organs harvested from a perfused wild-type mouse: kidney, heart, lungs,
liver, and pancreas (Figures 4-16). EHDs were triple stained along with DAPI and either
tomato lectin or isolectin b4. Tomato lectin (from Lycoperscion esculentum) is a lectin
that recognizes N-acetyl glucosamine (GlcNAc) and poly-N-acetyllactosamine and that is
used to stain endothelial cells (Porter et al. 1990). Isolectin B4 binds alpha-galactosyl
residues (Laitinen 1987).
Kidney
Confirming previous publications, EHD3 is exclusively expressed in the
glomerular endothelium and EHD1 and 2 are absent (Figure 5). Interestingly, EHD1 is
expressed along with EHD2 in segmental arteries that eventually branch into
efferent/afferent arterioles where EHD1 is absent (Figures 4 and 5). This suggests that
EHD1 staining becomes undetectable as renal arteries branch into smaller subsets.
Finally, EHD1, 2, and 3 are all undetectable in peritubular capillaries (Figure 6), which
was previously reported to express EHD4 (George et al. 2011).
Heart
As discussed above, EHD3 is important in cardiomyocyte function, but EHD
expression

within

endothelial

beds

of

the

heart

has

not

been

examined.

Immunofluorescent staining shows high levels of EHD2 expression throughout all

27

endothelial beds of the heart. The endocardium lines the inside of the heart (Figure 7)
and is positive for EHD2 and EHD3 expression. Epicardial arteries penetrate the
myocardium and become intramural arteries, which show positive staining for EHD2 and
3. Additionally, EHD1 expression appears detectable at low levels (Figure 8). Intramural
arteries eventually branch into arterioles. Veins within the myocardium express EHD2
and 3 while EHD1 is undetectable (Figure 9). Finally, myocardial microvessels, which
are highly prevalent in the myocardium, show high levels of EHD2, and no detectable
levels of EHD1 and EHD3 (Figure 10).
Lungs
Previous work suggested expression of EHD1 in the endothelium isolated from
Tie2GFP mouse lungs (Daneman et al. 2010). Immunofluorescent staining showed
positive staining for EHD 1, 2 and 3 in wild type mouse lungs. Pulmonary arteries
specifically show strong staining for EHD1 and EHD2. EHD3 is also expressed, but
staining is more prominent in the epithelium lining the bronchioles (Figure 11).
Additionally, there is positive staining for the three EHDs in pulmonary veins (Figure 12).
Finally, EHD 1 and 2 are expressed in the capillaries that align closely with the alveolar
epithelium (alveolar capillaries).
Liver
Studies have already established the expression of EHD3 in sinusoidal
endothelium within the liver, but nothing is known about other EHD proteins within the
sinusoids or other endothelial beds. Both hepatic arteries and portal veins deliver blood
to the sinusoids. Immunofluorescent staining showed positive staining for EHD1, EHD2,
and EHD3, but EHD1 was undetectable in the portal veins (Figures 13 and 14).
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Interestingly not only was EHD3 expressed in the liver sinusoids, but that staining
continued into the central veins where blood from the sinusoids is emptied (Figure 15).
Pancreas
Capillaries of the pancreas showed no detectable staining for EHD1, EHD2, and
EHD3 within both the islets of Langerhans and acinar cells (Figure 16 and 17). Because
of the lack of a reliable EHD4 antibody, it cannot be determined if EHD4 is expressed in
place of the other three EHD proteins. Similarly to their expression pattern in other
organs, EHD1 and 2 were expressed in the arteries of the pancreas while EHD1 was
undetectable in veins (Figure 18). EHD3 was undetectable in both (Figure 18).
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Figure 4: EHD protein expression in segmental arteries of the kidney. (A-P) 5 µm
thick kidney sections from perfused wild type mice were stained using antibodies
against EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei
(B, F, J, and N), and tomato lectin (green) labels endothelial cells (C, G, K, and O). EHD
staining (red) shows detectable levels of EHD1 (D) and EHD2 (H) in segmental arteries,
but not EHD3 (P). Scale Bar = 50 µm.
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Figure 5: EHD protein expression in glomerular endothelial cells and
afferent/efferent arterioles. (A-P) 5 µm thick kidney sections from perfused wild type
mice were stained using antibodies against EHD1, 2, and 3 and fluorescent images
were acquired. DAPI (blue) stains nuclei (B, F, J, and N), and tomato lectin (green)
labels endothelial cells (C, G, K, and O). EHD staining (red) shows detectable levels of
EHD3 in glomerular endothelial cells (P), but not EHD1 and EHD2 (H and L). EHD2 is
expressed in afferent/efferent arterioles adjacent to glomeruli (as noted with a white
arrow) but EHD1 or 3 are undetectable. Scale Bar = 50 µm.
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Figure 6: EHD protein expression in peritubular capillaries of the kidney. (A-P) 5
µm thick kidney sections from perfused wild type mice were stained using antibodies
against EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue) stains
nuclei (B, F, J, and N), and tomato lectin (green) labels endothelial cells (C, G, K, and
O). EHD staining (red) shows undetectable staining of EHD1, 2, or 3 in peritubular
capillaries (D, H, L, and P). EHD1 staining is positive in tubules, though (H). Scale Bar
= 50 µm.
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Figure 7: EHD protein expression in the endocardium. (A-P) 5 µm thick heart
sections from perfused wild type mice were stained using antibodies against EHD1, 2,
and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F, J, and N),
and isolectin B4 (green) labels endothelial cells (C, G, K, and O). EHD staining (red)
shows expression of EHD2 and EHD3 in the endocardium (L and P) and undetectable
staining of EHD1 in the endocardium (H). Scale Bar = 50 µm.
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Figure 8: EHD protein expression in intramural arteries of the heart. (A-P) 5 µm
thick heart sections from perfused wild type mice were stained using antibodies
against EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue) stains
nuclei (B, F, J, and N), and isolectin B4 (green) labels endothelial cells (C, G, K, and
O). EHD staining (red) shows detectable levels of EHD 1, 2, and 3 in intramural
arteries (H, L, and P). Scale Bar = 50 µm.
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Figure 9: EHD protein expression in veins of the heart. (A-P) 5 µm thick heart
sections from perfused wild type mice were stained using antibodies against EHD1, 2,
and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F, J, and
N), and isolectin B4 (green) labels endothelial cells (C, G, K, and O). EHD staining
(red) shows no detectable levels of EHD1 (H), but positive staining for EHD2 and
EHD3 (L and P). Scale Bar = 50 µm.
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Figure 10: EHD protein expression in myocardial microvessels. (A-P) 5 µm thick
heart sections from perfused wild type mice were stained using antibodies against
EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F,
J, and N), and isolectin B4 (green) labels endothelial cells (C, G, K, and O). EHD
staining (red) shows positive staining of EHD2 in the myocardial microvessels (L) and
undetectable levels of EHD1 and EHD3 (H and P). Bar = 50 µm.
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Figure 11: EHD protein expression in pulmonary arteries. (A-P) 5 µm thick lung
sections from perfused wild type mice were stained using antibodies against EHD1, 2,
and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F, J, and
N), and isolectin B4 (green) labels endothelial cells (C, G, K, and O). EHD staining
(red) shows positive staining for EHD1 and EHD2 (H and L) in pulmonary arteries and
low intensity staining for EHD3 (P). Scale Bar = 50 µm.
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Figure 12: EHD protein expression in pulmonary veins. (A-P) 5 µm thick lung
sections from perfused wild type mice were stained using antibodies against EHD1, 2,
and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F, J, and
N), and isolectin B4 (green) labels endothelial cells (C, G, K, and O). EHD staining
(red) shows positive staining for EHD1, 2, and 3 in pulmonary veins and EHD1 and 2
in alveolar endothelium (H, L, and P). Scale Bar = 50 µm.
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Figure 13: EHD protein expression in hepatic arteries. (A-P) 5 µm thick liver
sections from perfused wild type mice were stained using antibodies against EHD1, 2,
and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F, J, and
N), and tomato lectin (green) labels endothelial cells (C, G, K, and O). EHD staining
(red) shows detectable levels of EHD1, 2, and 3 in hepatic arteries (H, L, and P). Scale
Bar = 50 µm.
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Figure 14: EHD protein expression in hepatic portal veins. (A-P) 5 µm thick liver
sections from perfused wild type mice were stained using antibodies against EHD1, 2,
and 3 and fluorescent images were acquired. DAPI (blue) stains nuclei (B, F, J, and
N), and tomato lectin (green) labels endothelial cells (C, G, K, and O). EHD staining
(red) shows positive staining for EHD2 and EHD3 (L and P) in portal veins, but not
EHD1 (H). Scale Bar = 50 µm.
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Figure 15: EHD protein expression in liver sinusoids and central veins. (A-P) 5
µm thick liver sections from perfused wild type mice were stained using antibodies
against EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue) stains
nuclei (B, F, J, and N), and tomato lectin (green) labels endothelial cells (C, G, K, and
O). EHD staining (red) shows detectable levels of EHD3 in central veins and
surrounding sinusoids (P), but not EHD1 and EHD2 (H and L). Scale Bar = 50 µm.
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Figure 16: EHD protein expression in capillaries of the islet of Langerhans. (A-P)
5 µm thick pancreas sections from perfused wild type mice were stained using
antibodies against EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue)
stains nuclei (B, F, J, and N), and tomato lectin (green) labels endothelial cells (C, G,
K, and O). EHD staining (red) shows no detectable levels of EHD1, 2, or 3 in the
capillaries (H, L, and P). Scale Bar = 50 µm.
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Figure 17: EHD protein expression in capillaries among pancreatic acinar cells.
(A-P) 5 µm thick pancreas sections from perfused wild type mice were stained using
antibodies against EHD1, 2, and 3 and fluorescent images were acquired. DAPI (blue)
stains nuclei (B, F, J, and N), and tomato lectin (green) labels endothelial cells (C, G,
K, and O). EHD staining (red) shows no detectable levels of EHD1, 2, or 3 in the
capillaries (H, L, and P). Scale Bar = 50 µm.
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Figure 18: EHD protein expression in arteries and veins of the pancreas. (A-P) 5
µm thick pancreas sections from perfused wild type mice were stained using
antibodies against EHD1, 2, and 3 and fluorescent images were acquired. Tomato
lectin (green) labels endothelial cells (C, G, K, and O). EHD staining (red) shows
positive staining for EHD1 in arteries, but not veins (H), for EHD2 in both arteries and
veins (L), and for neither for EHD3 (P). Scale Bar = 50 µm.
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B. All EHD Proteins are Expressed in Multiple Endothelial Cell Lines
Many in vitro studies examining endothelial biology utilize commercially available
endothelial cell lines. Because immunofluorescent staining has shown differential
expression of EHD proteins within various endothelial beds, multiple cell lines were
analyzed via western blot analysis to see if such compartmentalization is lost in vitro.
Indeed, when comparing several endothelial cell lines all four EHD proteins are
expressed, although at varying levels (Figure 19). HUVECs are a primary cell line while
EA.Hy926 are HUVECs that have been immortalized by fusing them with a thioguanineresistant clone of A549 by exposure to polyethylene glycol (PEG) (Campos-Estrada et
al. 2015). The HMEC-1 line is isolated from the dermis and immortalized via the SV-40
antigen. Interestingly, within the three commercial cell lines used, the immortalized cell
lines expressed higher levels of EHD3 and reduced levels of EHD2. Comparing the
commercial lines to a primary cell line isolated from the mouse mammary fat pad (MFP
MVEC), EHD levels are again varying. When SV40 antigen is expressed in MFPMVECs, there is lower expression of EHD4.
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Figure 19: All EHD proteins are expressed in multiple endothelial cell lines. Cell
lysates containing 40 µg of protein were resolved by 7.5% SDS-PAGE and transferred
onto PVDF membranes which were subjected to immunoblotting with rabbit-antipeptide antisera raised against specific EHD proteins. Relative molecular weight
markers are indicated in kiloDaltons (kD). β-actin was used as a loading control.
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C. siRNA-Mediated Knockdown of EHD2 Does Not Affect VEGFA-Induced
Endothelial Cell Tubulation
Continuous endothelium contains the highest level of caveolae and also stained
the strongest for EHD2 (Figures 4-18). Since caveolin-1 has been linked to angiogenesis
and colocalizes with EHD2 in caveolae in other cell types, siRNA-mediated knockdown
of EHD2 was performed to assess the effects on tubulation in Matrigel. In vitro,
tubulation assays are utilized to test different conditions on the effects of angiogenesis
without the expense and difficulties of in vivo studies (Arnaoutova & Kleinman 2010).
Western blot analysis (Figure 20A) confirmed reduction in EHD2 upon treatment with
siRNA. Immunoblotting for remaining EHD proteins showed no increase or decrease in
levels upon knockdown of EHD2. Because tubulation was stimulated by VEGFA ligand,
protein levels for VEGFR2 were assessed as well. VEGFR2 protein levels appear to
remain the same after EHD2 knockdown (Figure 20A). Figure 20B are the 8-bit
converted images collected after the tubulation assay was completed. Visually, there
appears to be no difference in tubulation between EHD2 knockdown and control,
although the EHD2 knockdown tubules may appear thicker. Figure 20C and D show
tubule branch point and tubule counts, both means for quantifying tubulation
(Arnaoutova & Kleinman 2010). Comparing cells treated with control siRNA to those
treated with EHD2 siRNA branch points and tubule counts are approximately the same,
and this is true with or without VEGFA stimulation. Taken together, this suggests that siRNA mediated EHD2 knockdown does not affect tubulation in vitro.
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Figure 20: siRNA-mediated knockdown of EHD2 does not affect VEGFA-induced tubulation in
EA.Hy926 cells. Cells were treated with non-targeting, EHD1 and EHD2 siRNAs. Western blot
analysis (A) confirms reduction in EHD1 and EHD2 as well as an increase in VEGFR2 with EHD1
reduction. B-D shows 8-bit representations of imaged cells and perimeter measurements to
represent tubulation. Non-targeting (B) shows a slight increase in tubulation upon VEGFA (50 ng/ml)
stimulation compared to media alone. EHD1 (C) and EHD2 (D) reduction showed a marked increase
in tubulation in comparison (E). Sulforaphane (15µm) was used to inhibit tubulation.
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CHAPTER 4: DISCUSSION
The vasculature is implicated in most, if not all, diseases. In order to fully harness
the therapeutic potential of the endothelium, research must focus on understanding the
heterogeneity of ECs. As mentioned in Table 1, one area in which ECs may vary is the
genes/proteins they express. Immunofluorescent staining of multiple organs in wild type
mice have shown that three of the four mammalian EHD proteins (EHD1-3) are not
equally expressed throughout different endothelial beds, but some patterns seem to be
evident.
Immunofluorescent staining of selected organs showed the strongest staining for
EHD1 in arteries (except for efferent/afferent arterioles of the kidney) and no detectable
staining in veins. When comparing arteries to veins, arteries have higher numbers of
tight junctions due to higher blood pressure (Aird 2007b). As previously mentioned,
EHD1 was also upregulated in cells cultured to mimic the blood brain barrier, another
endothelial bed rich in tight junctions. Tight junctions (TJ) are found in many polarized
cells and include occludin, claudins, and junction adhesion molecule (JAM) (GonzálezMariscal et al. 2003). Tight junctions are dynamic and are trafficked through the cell.
Internalization of tight junctions can occur via clathrin-dependent and clathrinindependent pathways, and they then can be sent to the lysosome for degradation, to
the trans-golgi network via the retrotransport pathway, or recycled back to the plasma
membrane (Chalmers & Whitley 2012). Analysis of eye defects associated with the
Ehd1-null mouse displayed irregular staining of ZO-1, an occludin TJ, within the lens
epithelium (Arya et al. 2015). Taken together, these results suggest that EHD1 may play
a role in the trafficking of tight junctions in endothelial cells. Interestingly, EHD1 shows
strong expression in the pulmonary arteries and veins of the lung in addition to potential
expression in alveolar capillaries. Capillaries of the lungs closely associate with alveoli to
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accommodate gas exchange. It is possible that EHD proteins may be important in
endothelial maintenance during this process.
In line with previous publications, our results suggest that EHD2 is prevalent in
many endothelial beds except for some smaller capillaries, including peritubular
capillaries of the kidney and sinusoids and central veins of the liver. As mentioned
above, endothelial cells, in general, contain higher levels of caveolae compared to other
cell types. EHD2 staining was positive in the endothelial beds that contained the most
caveolae, i.e. continuous endothelium. The strongest staining was seen in arteries,
which have the most caveolae of all blood vessels. Because ECs are exposed to high
levels of shear flow, particularly in the arteries, cell membrane repair is an essential
process to maintain the endothelial barrier. Currently, the proposed mechanism for
membrane repair upon injury involves calcium influx that is sensed by myoferlin localized
to caveolae along with caveolin-1. This induces dynamin-dependent endocytosis and
subsequent “patching” of the damaged membrane (Bernatchez et al. 2009; Cipta & Patel
2009). As mentioned above, EHD2 is known to interact with myoferlin and localizes to
the site of injury in myoblasts along with dysferlin, another ferlin family member. Knowing
that EHD2 localizes to caveolae and interacts with caveolin-1, it is possible that EHD2
plays a role in the membrane repair process in endothelial cells. Due to its localization at
the site of injury and its role in myoblast fusion along with myoferlin, both in myoblasts, it
further possible that EHD2 may also be involved in the “patching” step of the proposed
repair process. In addition to membrane repair, myoferlin has also been implicated in the
recycling of vascular endothelial growth factor receptor 2 (VEGFR2) via a caveolaedependent mediated endocytic pathway (Bernatchez et al. 2007). If EHD2 interacts with
myoferlin in ECs, it is possible that EHD2 could also be involved in the trafficking of
VEGFR2.
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EHD3 expression was consistently low in arteries, but uniquely present in
glomerular endothelial cells and liver sinusoids as previously described. Another type of
fenestrated endothelial bed includes the presence of diaphragms and includes
peritubular capillaries in the kidney and capillaries in the pancreas. As previously
mentioned, EHD4 is expressed in peritubular capillaries. Interestingly, no staining of
EHD1, 2, or 3 was evident in the pancreatic capillaries. Taken together, EHD4 is
predicted to be expressed in the pancreatic microvasculature and immunofluoresecent
staining will need to be confirmed to perform this.
A potential role for EHD3, and even EHD4, is the regulation of fenestrae
development in fenestrated and discontinuous endothelial cells. As previously
mentioned, combined Ehd3 and Ehd4 deletion in mice causes renal pathology and
abnormal localization of VEFGR2 in glomerular ECs. Research has shown that VEGFR2
signaling may play an important role in the formation of fenestrae in both glomerular ECs
and liver sinusoids (Satchell & Braet 2009; Carpenter et al. 2005). In brief, it is thought
that VEGFR2 activation via VEGFA results in downstream actin rearrangement and
recruitment of plasmalemmal vesicle-associated protein-1 (PV-1). PV-1 then assists in
the formation of fenestrae and is later removed (Satchell & Braet 2009). EHD3, and
perhaps EHD4, may be involved in the trafficking of VEGFR2 during VEGFA signaling
specifically involved in fenestrae formation. Endothelial-specific deletion of Ehd3 and
Ehd4 may be able to shed light on this process.
In addition to characterizing EHD proteins in endothelial beds of different organs,
it is now known that EHD proteins are expressed in multiple endothelial cell lines. Unlike
the expression patterns seen in tissues, though, there is much broader expression of all
four EHD proteins in the four cell lines examined in this study. It is possible that the
environment of an endothelial cell greatly influences its EHD protein expression patterns
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within specific tissues. It is also possible that isolating more specific endothelial beds,
such as glomerular endothelial cells, will show EHD expression similar to what is seen in
vivo. Additionally, it appears that immortalization procedures affect the expression of
some EHD proteins. HMEC-1 and EA.Hy926 have both been immortalized after isolation
and both have increased levels of EHD3 and reduced levels of EHD4 compared to
HUVEC, which is a primary cell line.
Finally, according to the tubulation experiments, siRNA-mediated reduction in
EHD2 did not alter VEGFA-induced tubulation of endothelial cells in Matrigel (Figure 20).
Other EHD protein levels appear unaffected by EHD2 reduction, and could be
compensating for the reduction in EHD2 (mainly EHD1 or EHD4). Additional in vitro
studies will need to be performed to explore this further, including assessing the effects
of EHD2 knockdown on endothelial cell invasion and migration.
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CHAPTER 5: CONCLUSIONS AND FUTURE PROSPECTS
EHD proteins are highly conserved endocytic regulators and have both
redundant and unique functions. Their differential expression within endothelial beds has
further contributed to the heterogeneous nature of ECs. Despite adding to the complexity
of the field of endothelial biology, it is apparent there are patterns in EHD expression and
novel functions for these proteins in ECs may soon be identified. To further understand
the importance of EHD proteins in vivo in the context of vascular research, similar
immunostaining or histological analysis should be carried out on current knockout mouse
models that are readily available. Currently, no vascular defects have been reported in
knockout mice beyond the study performed in mice with combined Ehd3 and Ehd4
deletion (George et al. 2011). Due to its high expression in continuous endothelial cells
and most blood vessels, an Ehd2 knockout mouse would be of great interest to study.
Currently, there are no publications characterizing Ehd2 knockout mice. Additionally, an
effective, specific EHD4 antibody must be established so that complete characterization
can be accomplished. In addition to total knockout mice, endothelial-specific deletion
models can also be utilized. Multiple mouse models have been established and could
allow for analysis of mice with combined deletions that may be lethal in a whole system
knockout model (Gustafsson et al. 2001; Kisanuki et al. 2001; Alva et al. 2006).
In vitro studies have been crucial to help understand the function of EHD proteins
in endocytic trafficking. EC lines should likewise be used to better understand EHD
proteins in endothelial biology. Another way to induce more accurate representation of
an endothelial bed environment in vitro could include co-culturing ECs with other cell
types, similarly to the study done with bovine brain capillary cells and glial cells. Finally,
another way to recreate a physiological environment could include 3-D culture, similarly
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to what was done in the tubulation assay, or exposing ECs to shear flow with machines
such as a BioFlux.
Caveolae are prominent in ECs and function in many processes. Due to high
expression of EHD2 in continuous endothelium, which has the highest levels of
caveolae, and the fact that it interacts with caveolin-1, EHD2 is possibly playing a role in
some of these functions as well, including membrane repair and angiogenesis. Due to
their more compartmentalized expression patterns in fenestrated and discontinuous
endothelium, EHD3 and 4 may be important in the development of fenestrae via
VEGFR2 recycling. Examining other organs with such beds should include the spleen,
bone marrow, endocrine glands, and intestines.
Understanding the role of EHD proteins in endothelial biology will not only
provide useful physiological information, but also provide insight into future therapeutic
targets. The vascular system has access to every tissue and organ in the body and is a
desirable target for drug delivery. One route for drug delivery utilizes the endocytic
pathways of endothelial cells to deliver therapeutics to underlying tissues. Understanding
EHD proteins in the context of endothelial cells will help to further this area of research
and improve upon drug therapies for multiple diseases.
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